Interesting. And confusing .. like CYDY results.
Post# of 148155
Maybe I misunderstood their presentation, and will hear more in a few hours.
Will see if they are as transparent as CYDY with presentation of full results. It certainly appears their subgroup analysis was significant, but need more information. Will see if FDA goes for EUA, and how quickly it responds to theirs and CYDYs based on subgroup analysis. I don't remember the 28 day endpoint being significant before but now it is?